SERA PROGNOSTICS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • May 5th, 2021 • Sera Prognostics, Inc. • Services-medical laboratories • Utah
This Employment Agreement (this “Agreement”) is effective for all purposes as of January 27, 2015 (the “Effective Date”), by and between Sera Prognostics, Inc., a Delaware corporation (the “Company”), and Douglas C. Fisher (the “Employee”).
SECOND AMENDMENT TO COMMERCIALIZATION AGREEMENTCommercialization Agreement • May 5th, 2021 • Sera Prognostics, Inc. • Services-medical laboratories
THIS Second Amendment to the January 9, 2017 Commercialization Agreement (“Second Amendment”), effective as of the date this Second Amendment is signed by both parties (the “Effective Date”), is made by and between Sera Prognostics, Inc. (“Sera”) and Laboratory Corporation of America Holdings (“Labcorp”). Sera and Labcorp may be referred to herein each as a “Party” or collectively as “Parties.”
June 19, 2020Separation Agreement • May 5th, 2021 • Sera Prognostics, Inc. • Services-medical laboratories • Utah
COMMERCIAL COLLABORATION AGREEMENTCommercial Collaboration Agreement • May 5th, 2021 • Sera Prognostics, Inc. • Services-medical laboratories • New York
This Commercial Collaboration Agreement (this “Agreement”), dated as of February 17, 2021 (the “Effective Date”), is made by and between Anthem, Inc. and its Affiliates (as defined below) (collectively, “Anthem”) on the one hand, and Sera Prognostics, Inc. (“Company”) on the other hand.
COMMERCIALIZATION AGREEMENTCommercialization Agreement • May 5th, 2021 • Sera Prognostics, Inc. • Services-medical laboratories • Delaware
This Commercialization Agreement (“Agreement”) is effective as of January 9, 2017 (“Effective Date”) and is entered into by and between Sera Prognostics, Inc. (“Sera”), a Delaware corporation with its principal place of business at 2749 East Parleys Way, Suite 200, Salt Lake City, Utah 84109, and Laboratory Corporation of America Holdings (“LabCorp”), a Delaware corporation with its principal place of business at 531 South Spring Street, Burlington, North Carolina 27215. Each of Sera and LabCorp is referred to herein as a “Party” and together as the “Parties.”
First Amendment to Commercialization AgreementCommercialization Agreement • May 5th, 2021 • Sera Prognostics, Inc. • Services-medical laboratories
This First Amendment to Commercialization Agreement (“Amendment”) is made and shall be effective upon the date this Amendment is signed by both Parties (“Amendment Date”) by and between Sera Prognostics, Inc. (“Sera”), a Delaware corporation with its principal place of business at 2749 East Parleys Way, Suite 200, Salt Lake City, Utah 84109, and Laboratory Corporation of America Holdings (“LabCorp”), a Delaware corporation with its principal place of business at 531 South Spring Street, Burlington, North Carolina 27215. Each of Sera and LabCorp is referred to herein as a “Party” and together as the “Parties.”
LABORATORY SERVICES AGREEMENT PRIMESTUDYLaboratory Services Agreement • May 5th, 2021 • Sera Prognostics, Inc. • Services-medical laboratories • Utah
This Laboratory Services Agreement (“Agreement”) is made and entered into effective as of November 10, 2020 (“Effective Date”) by and between Anthem Health Insurance and Amerigroup Corporation, whose principal place of business is 4425 Corporation Lane Virginia Beach, VA 23462 (hereinafter referred to collectively as “Anthem”), and Sera Prognostics, Inc., whose principal place of business is 2749 East Parleys Way, Suite 200, Salt Lake City, UT 84109 (“Laboratory”).
